While the benefits of AI are clear, the amount data sets needed for effective AI integration is proving to be a challenge.
Next-generation CAR T-cell therapies aim to improve accessibility, durability, and effectiveness, addressing current ...
As the many challenges facing cell therapies are being addressed, the CAR T field continues to evolve beyond its original ...
Recent research indicates that the spatial architecture of membrane proteins is crucial for regulating T-cell signaling and activation. 3-5 In the context of CAR T cells, the nanoscale localization ...
Bristol Myers Squibb will acquire Orbital Therapeutics for $1.5B, expanding its RNA medicine and in vivo CAR T-cell therapy capabilities.
Explore how regenerative medicine is transforming healing and restoration in healthcare, and discover its potential benefits ...
In vivo CD19 CAR T-cell therapy showed promising results in a feasibility study of five patients with refractory systemic ...
Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...
Takeda is looking to offload its cell therapy platform and preclinical assets to a yet-unidentified external partner. 137 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback